FR2120040A1 - - Google Patents

Info

Publication number
FR2120040A1
FR2120040A1 FR7146835A FR7146835A FR2120040A1 FR 2120040 A1 FR2120040 A1 FR 2120040A1 FR 7146835 A FR7146835 A FR 7146835A FR 7146835 A FR7146835 A FR 7146835A FR 2120040 A1 FR2120040 A1 FR 2120040A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7146835A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FR2120040A1 publication Critical patent/FR2120040A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7146835A 1970-12-28 1971-12-27 Withdrawn FR2120040A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP45124064A JPS4935635B1 (fr) 1970-12-28 1970-12-28

Publications (1)

Publication Number Publication Date
FR2120040A1 true FR2120040A1 (fr) 1972-08-11

Family

ID=14876047

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7146835A Withdrawn FR2120040A1 (fr) 1970-12-28 1971-12-27

Country Status (8)

Country Link
US (1) US3819613A (fr)
JP (1) JPS4935635B1 (fr)
BE (1) BE777223A (fr)
CA (1) CA952102A (fr)
DE (1) DE2163790A1 (fr)
FR (1) FR2120040A1 (fr)
HU (1) HU164525B (fr)
NL (1) NL7117787A (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4157443A (en) * 1976-11-11 1979-06-05 Ciba-Geigy Corporation V-Triazolyl-[4,5-d]-pyrimidines
US5155098A (en) * 1989-06-09 1992-10-13 Hoechst-Roussel Pharmaceuticals Inc. N-heteroaryl-purin-6-amines, and pharmaceutical compositions and methods employing them
US5017578A (en) * 1989-06-09 1991-05-21 Hoechst-Roussel Pharmaceuticals Inc. N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents
US5278150A (en) * 1992-04-24 1994-01-11 Whitby Research, Inc. 2-hydrazoadenosines and their utility for the treatmeat of vascular conditions
DK62592D0 (fr) * 1992-05-14 1992-05-14 Novo Nordisk As
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
EP0704215A3 (fr) 1994-06-02 1998-04-01 Takeda Chemical Industries, Ltd. Inhibiteur de l'aumentation de la perméabilité vasculaire
WO1999017784A1 (fr) 1997-10-07 1999-04-15 Regents Of The University Of California Corporation Traitement de la vasculopathie peripherique obliterante et de la coronarite au moyen de conbinaisons d'heparine et d'un agoniste a2 adenosine, ou au moyen d'adenosine
US5972903A (en) * 1997-10-07 1999-10-26 Regents Of The University Of California Corporation Method for promoting angiogenesis using heparin and adenosine
EA011826B1 (ru) * 2004-05-26 2009-06-30 Инотек Фармасьютикалз Корпорейшн Пуриновые производные в качестве агонистов аденозиновых арецепторов и способы их применения
JP5203214B2 (ja) * 2005-11-30 2013-06-05 イノテック ファーマシューティカルズ コーポレイション プリン化合物およびその使用方法
SI2523669T1 (sl) 2010-01-11 2017-05-31 Inotek Pharmaceuticals Corporation Kombinacija, komplet in metoda za zmanjšanje intraokularnega tlaka
WO2011119969A1 (fr) 2010-03-26 2011-09-29 Inotek Pharmaceuticals Corporation Procédé de réduction de la pression intraoculaire chez l'homme à l'aide de n6-cyclopentyladénosine (cpa), de dérivés ou de promédicaments de cpa
DK2807178T3 (en) 2012-01-26 2017-09-04 Inotek Pharmaceuticals Corp Anhydrous polymorphs of (2R, 3S, 4R, 5R) -5- (6- (cyclopentylamino) -9H-purin-9-yl) -3,4-dihydroxytetrahydrofuran-2-yl) methyl nitrate and processes for their preparation
SG11201506882YA (en) 2013-03-15 2015-09-29 Inotek Pharmaceuticals Corp Ophthalmic formulations
CN114127070A (zh) * 2019-06-21 2022-03-01 中国人民解放军军事科学院军事医学研究院 具有a2a腺苷受体激动剂活性的6-肼基腺苷类化合物

Also Published As

Publication number Publication date
JPS4935635B1 (fr) 1974-09-25
HU164525B (fr) 1974-02-28
CA952102A (en) 1974-07-30
US3819613A (en) 1974-06-25
NL7117787A (fr) 1972-06-30
BE777223A (fr) 1972-06-23
DE2163790A1 (de) 1972-07-20

Similar Documents

Publication Publication Date Title
JPS4935635B1 (fr)
AU1473870A (fr)
AU1146470A (fr)
AU2044470A (fr)
AU1336970A (fr)
AU2085370A (fr)
AU1517670A (fr)
AU1716970A (fr)
AU1833270A (fr)
AU1326870A (fr)
AU2017870A (fr)
AU2130570A (fr)
AU1881070A (fr)
AU1343870A (fr)
AU2115870A (fr)
AU2061170A (fr)
AU2119370A (fr)
AU1277070A (fr)
AU1974970A (fr)
AU1969370A (fr)
AU1943370A (fr)
AU1918570A (fr)
AU2131570A (fr)
AU1879170A (fr)
AU1872870A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse